Skip to main content
Indo US Bio-Tech Limited logo

Indo US Bio-Tech Limited — Investor Relations & Filings

Ticker · INDOUS ISIN · INE250Z01010 LEI · 335800C8LDCWCED9W826 BSE.NS Agriculture, forestry and fishing
Open in API
Filings indexed 110 across all filing types
Latest filing 2026-01-21 Regulatory Filings
Country IN India
Listing BSE.NS INDOUS

About Indo US Bio-Tech Limited

https://indousagriseeds.com/

Indo US Bio-Tech Limited specializes in the research, development, and production of high-quality hybrid seeds. The company focuses on creating genetically superior seeds for a wide range of crops, including vegetables, oilseeds, pulses, and cereals. Key products include hybrid varieties of tomato, chili, okra, castor, and maize. The organization emphasizes agricultural innovation through its dedicated research and development facilities, aiming to enhance crop yields, improve disease resistance, and ensure climate adaptability. By leveraging advanced biotechnological techniques, the company provides sustainable solutions and high-performance seeds tailored to diverse agro-climatic conditions.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings
2026-01-21 English
Outcome of Board Meeting
Regulatory Filings
2026-01-21 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-01-12 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notification of a scheduled Board Meeting to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2025. It is an intimation letter sent to stock exchanges pursuant to regulatory requirements, informing about the upcoming board meeting and trading window closure. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is a short notice primarily serving as an announcement of a future event related to financial reporting. Therefore, it fits the category of Regulatory Filings (RNS) as a general regulatory announcement rather than an Interim/Quarterly Report (IR) or Earnings Release (ER).
2026-01-12 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025. It is issued by the Registrar and Share Transfer Agent and confirms details about securities dematerialization for the quarter. The document is short (2919 characters) and primarily serves as a compliance certificate rather than a financial report or detailed filing. It does not contain financial statements or substantive financial data. Therefore, it fits best under Regulatory Filings (RNS), which covers officer certifications, attestations, and compliance confirmations that do not qualify as full reports.
2026-01-07 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the closure of the trading window for insiders ahead of the announcement of unaudited quarterly financial results. It references the upcoming unaudited financial results for the quarter ending December 31, 2025, but does not contain any financial data or the results themselves. The document is short (1564 characters) and serves as a notification related to compliance with insider trading regulations rather than a financial report or earnings release. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2025-12-31 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.